TALIS BIOMEDICAL CORP (TLIS)
US87424L2079 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 76.73M | 130.20M | 232.50M | 138.50M | 21.60M | |||
| Receivables | 50.00K | 300.00K | 200.00K | 500.00K | 1.80M | |||
| Other Current Assets | 901.00K | 2.80M | 3.40M | 49.80M | 700.00K | |||
| Total Current Assets | 77.68M | 133.30M | 236.10M | 188.70M | 24.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 15.45M | 34.20M | 23.40M | 9.70M | 1.50M | |||
| Other Non-Current Assets | 1.54M | 1.80M | 6.30M | 0.00 | 100.00K | |||
| Total Non-Current Assets | 16.99M | 36.00M | 29.70M | 9.70M | 1.60M | |||
| TOTAL ASSETS | 94.67M | 169.30M | 265.80M | 198.40M | 25.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 7.43M | 8.90M | 12.90M | 10.40M | 1.90M | |||
| Accounts Payable | 1.34M | 3.80M | 5.10M | 4.90M | 1.60M | |||
| Other Current Liabilities | N/A | N/A | 1.10M | 700.00K | 600.00K | |||
| Total Current Liabilities | 8.77M | 12.70M | 19.10M | 16.00M | 4.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 16.79M | 29.90M | 12.70M | 0.00 | 100.00K | |||
| Total Non-Current Liabilities | 16.79M | 29.90M | 12.80M | 0.00 | 100.00K | |||
| TOTAL LIABILITIES | 25.56M | 42.60M | 31.90M | 16.00M | 4.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -539.96M | -478.00M | -364.90M | -172.90M | -81.80M | |||
| Additional Paid In Capital | 609.07M | 604.70M | 598.90M | 64.30M | 60.60M | |||
| Common Shares | 3.18K | 0.00 | 0.00 | 290.90M | 42.80M | |||
| Other Shareholders' Equity | -180.00 | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 1.82M | 1.80M | 1.80M | 1.60M | 1.60M | |||
| Tangible Book Value per Share | 37.93 | 70.39 | 130.00 | -67.81 | -13.25 | |||
| Total Shareholders' Equity | 69.12M | 126.70M | 234.00M | 182.40M | 21.60M | |||
| TOTAL LIABILITIES AND EQUITY | 94.67M | 169.30M | 265.80M | 198.40M | 25.70M | |||
| Statistics | ||||||||
| Current Ratio | 8.86 | 10.50 | 12.36 | 11.79 | 6.03 | |||
| Return On Assets (ROA) | -65.50% | -66.75% | -72.25% | -45.93% | 102.65% | |||
| Return On Equity (ROE) | -89.71% | -89.19% | -82.07% | -49.96% | 122.13% | |||
All data in USD